+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

From
From
Monoclonal Antibody Discovery and Analysis Market Report 2022-2032 - Product Thumbnail Image

Monoclonal Antibody Discovery and Analysis Market Report 2022-2032

  • Report
  • December 2022
  • 437 Pages
  • Global
From
From
From
Global Markets for Bioengineered Protein Drugs - Product Thumbnail Image

Global Markets for Bioengineered Protein Drugs

  • Report
  • March 2023
  • 185 Pages
  • Global
From
From
Uveitis Treatment - Global Strategic Business Report - Product Thumbnail Image

Uveitis Treatment - Global Strategic Business Report

  • Report
  • November 2024
  • 194 Pages
  • Global
From
From
Diabetic Retinopathy Treatment - Global Strategic Business Report - Product Thumbnail Image

Diabetic Retinopathy Treatment - Global Strategic Business Report

  • Report
  • November 2024
  • 273 Pages
  • Global
From
From
Bioengineered Protein Drugs Global Market Report 2024 - Product Thumbnail Image

Bioengineered Protein Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Loading Indicator